|
|
Article: New research on neoplasms immunology from Rabin Medical Center summarized.(Report)
- Article from:
- Cancer Weekly
- Article date:
- June 30, 2009
CopyrightCOPYRIGHT 2009 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
New research, 'Quantitative colonoscopic evaluation of relative efficiencies of an immunochemical faecal occult blood test and a sensitive guaiac test for detecting significant colorectal neoplasms,' is the subject of a report. According to a study from Israel, "The guaiac faecal occult blood test (G-FOBT), HemoccultSENSA, is sensitive for significant neoplasms [colorectal cancer (CRC), advanced adenomatous polyps (AAP)], but faulted by non-specificity for human haemoglobin (Hb). Quantified, Hb-specific, immunochemical faecal occult blood tests (I-FOBT) are now used."
"To (i) compare I-FOBT and G-FOBT efficacy in identifying significant neoplasms and colonoscopy ...
Related newspaper, magazine, and journal articles:
|
|
Article: FOBT screening does not reduce all-cause ...
JAAPA-Journal of the American Academy of Physicians Assistants;
June 1, 2006 ;
700+ words
... ... question Does fecal occult blood testing (FOBT) reduce all-cause mortality? Bottom line Screening for colorectal cancer using FOBT does not reduce all-cause mortality ... them live a longer life. Is that true of FOBT? The authors combined data from the three ...
|
|